Home › Funds › Capital International Sarl › VRTX

Capital International Sarl position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Capital International Sarl reported holding 223,922 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$117.1M, representing 1.59% of its reported portfolio and ranking #14 among its reported holdings. Capital International Sarl has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)223.92K sh
Reported value held$117.07M
Portfolio Weight1.59%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Capital International Sarl's VRTX position evolved

Capital International Sarl first disclosed a stake in VRTX in Q3 2023 at 79,474 shares (US$27.6M). The position peaked in Q3 2026 at 223,922 shares, worth US$117.1M. Across 13 filings, Capital International Sarl increased the stake 11 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 223,922 shares valued at US$117.1M — an increase of 13,204 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 79.47K $27.64M New
Q4 2023 93.59K $38.08M Add
Q1 2024 116.48K $48.69M Add
Q2 2024 124.08K $58.16M Add
Q3 2024 143.05K $66.53M Add
Q4 2024 168.59K $67.89M Add
Q1 2025 186.17K $90.26M Add
Q2 2025 223.39K $99.45M Add
Q3 2025 225.73K $88.41M Add
Q4 2025 193.44K $87.70M Reduce
Q1 2026 208.88K $93.27M Add
Q2 2026 210.72K $104.67M Add
Q3 2026 223.92K $117.07M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Capital International Sarl held VRTX?

Capital International Sarl has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Capital International Sarl's current position in VRTX?

As of Q3 2026, Capital International Sarl holds 223.92K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $117.07M, representing 1.59% of its reported portfolio and ranking #14.

Has Capital International Sarl been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Capital International Sarl increased its position in VRTX. The position peaked in Q3 2026 at 223.92K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.